Clinical Significance of mTOR and p-mTOR Protein Expression in Human Colorectal Carcinomas

被引:0
|
作者
Wang, Di [1 ,2 ]
Chen, Jian [2 ]
Guo, Fengjie [2 ]
Chen, Hui [2 ]
Duan, Zhi [2 ]
Wei, Mei-Yan [2 ]
Xu, Qi-Mei [2 ]
Wang, Liang-Hua [2 ]
Zhong, Mei-Zuo [1 ]
机构
[1] Cent S Univ, Xiangya Hosp, Dept Canc, Changsha, Hunan, Peoples R China
[2] First Hosp Changsha, Changsha, Hunan, Peoples R China
关键词
Colorectal cancer; mTOR; p-mTOR; immunohistochemistry; overexpession; MAMMALIAN TARGET; CANCER; RAPAMYCIN; PATHWAY; INHIBITOR; GROWTH; ACTIVATION; TUMORS; COLON; LUNG;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To investigate the significance of mammalian target of rapamycin (mTOR) and its active form, p-mTOR in colorectal carcinomas. Methods: Immunohistochemistry was used to detect the expression of mTOR and p-mTOR proteins in 108, 40 and 40 tissue samples from colorectal carcinoma, normal colonic mucosa and adenomatous polyps samples, respectively. The correlation of mTOR and p-mTOR expression with clinicopathological characteristics of colorectal carcinoma was analyzed. Results: The positive rates of mTOR and p-mTOR were significantly higher in colorectal carcinoma (61.1% and 61.1%, respectively, p<0.05) than in normal colonic mucosa (7.5% and 2.5%) and adenomatous polyps (27.5% and 20%). Overexpression of total mTOR protein was significantly associated with T1/T2 stage tumors, lymph node metastasis, distal metastasis) and degree of differentiation. p-mTOR overexpression was additionaly linked with degree of differentiation and TNM stage. Conclusion: The overexpression of mTOR and p-mTOR may play important roles in colorectal carcinogenesis with relations to the degree of differentiation, invasiveness and metastasis.
引用
收藏
页码:2581 / 2584
页数:4
相关论文
共 50 条
  • [31] mTOR expression in colorectal adenoma-reply
    Gopalan, Vinod
    Smith, Robert Anthony
    Lam, Alfred King-yin
    HUMAN PATHOLOGY, 2014, 45 (04) : 897 - 897
  • [32] The expression of p-mTOR and COUP-TFII correlates with increased lymphangiogenesis and lymph node metastasis in prostate adenocarcinoma
    Lilis, Ioannis
    Giopanou, Ioanna
    Papdaki, Helen
    Gyftopoulos, Kostis
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 311.e27 - 311.e35
  • [33] Sub-Flap Use of Nano-Selenium Oxide Solution Enhances Skin Flap Viability in Rats: Study the Novel Role of mTOR and p-mTOR Expression
    Omid Akhiani
    Nasim Zangouie
    Reza Laripour
    Amir Rashidian
    Mohsen Ebrahimi
    Zahra Hami
    Mohsen Chamanara
    Aesthetic Plastic Surgery, 2022, 46 : 1452 - 1462
  • [34] Expression of PI3K/p-AKT/p-mTOR in gastric carcinoma and its correlation with clinicopathologic characteristics
    Jieer, Ying
    Qi, Xu
    Liu Bixia
    Cheng Xiangdong
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [35] Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer
    Lazaridis, Georgios
    Lambaki, Sofia
    Karayannopoulou, Georgia
    Eleftheraki, Anastasia G.
    Papaspirou, Irene
    Bobos, Mattheos
    Efstratiou, Ioannis
    Pentheroudakis, George
    Zamboglou, Nikolaos
    Fountzilas, George
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (07) : 636 - +
  • [36] Sub-Flap Use of Nano-Selenium Oxide Solution Enhances Skin Flap Viability in Rats: Study the Novel Role of mTOR and p-mTOR Expression
    Akhiani, Omid
    Zangouie, Nasim
    Laripour, Reza
    Rashidian, Amir
    Ebrahimi, Mohsen
    Hami, Zahra
    Chamanara, Mohsen
    AESTHETIC PLASTIC SURGERY, 2022, 46 (03) : 1452 - 1462
  • [37] Characterization of the expression of p-s6rb protein, a key mediator of the mTOR pathway, in invasive carcinomas of the breast
    Witkiewicz, A. K.
    Kleer, C. G.
    LABORATORY INVESTIGATION, 2008, 88 : 60A - 60A
  • [38] Characterization of the expression of p-s6rb protein, a key mediator of the mTOR pathway, in invasive carcinomas of the breast
    Wukiewicz, A. K.
    Kleer, C. G.
    MODERN PATHOLOGY, 2008, 21 : 60A - 60A
  • [39] Effects of propofol on LC3II and mTOR/p-mTOR expression during ischemia-reperfusion myocardium injury in rats with type 2 diabetes mellitus
    Wang, Ying
    Zhang, Kecheng
    Qi, Xiuru
    Yang, Guang
    Wang, Hongjie
    Zhang, Zhe
    Yang, Baofeng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (04) : 2441 - 2448
  • [40] Pancreatic Location, High Proliferation and Low p-mTOR Expression Levels Are More Frequent in Neuroendocrine Tumor Patients Responsive to mTOR Inhibitors: Results from a Preliminary Study
    Birocco, N.
    Brizzi, M. P.
    Airoldi, M.
    De Angelis, C.
    Ciuffreda, L.
    Maletta, F.
    Piovesan, A.
    Rapa, I
    Sapino, A.
    Scaldaferri, M.
    Scagliotti, G.
    Papotti, M.
    Volante, M.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 128 - 128